Companion Dog Cancer Immunotherapy

Advances in cancer immunotherapy for dogs are extending quality of life for cancer patients while maintaining welfare through targeted treatment approaches.

Key Facts

Cancer immunotherapy including checkpoint inhibitors and cancer vaccines is being developed for dogs
USDA-approved melanoma vaccine extends survival in some dogs with this cancer
Metronomic chemotherapy protocols use low doses that maintain quality of life better than traditional protocols
Clinical trials for new cancer treatments benefit both enrolled dogs and future patients
Veterinary oncology specialists provide access to advanced treatment options not available in general practice

Welfare Considerations

Cancer immunotherapy represents a welfare advance over conventional high-dose chemotherapy because it maintains better quality of life while fighting disease. Targeted treatments reduce the immune suppression and nausea associated with conventional chemotherapy. Access to veterinary oncology specialists enables individual dogs to receive treatments that maximise both survival and welfare. Clinical trial participation offers access to novel treatments while advancing knowledge that benefits future patients.

What You Can Do

Seek veterinary oncology referral when your dog is diagnosed with cancer
Ask about metronomic protocols that maintain quality of life alongside disease management
Consider clinical trial participation for dogs with cancer to access novel treatments